355 filings
Page 8 of 18
424B5
engvlrr gx3xb11tm
8 Mar 18
Prospectus supplement for primary offering
12:00am
8-K
nenqybly83 cw8
1 Mar 18
VolitionRX Limited Announces Full Fiscal Year 2017 Financial Results and Business Update
12:00am
8-K
ea07d 4mozv251
9 Nov 17
VolitionRx Limited Announces Third Quarter 2017 Financial Results and Business Update
12:00am
S-8
5hcpdjd jhl
20 Oct 17
Registration of securities for employees
12:00am
8-K
7bgz 8a60
21 Sep 17
VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding
12:00am
8-K
ja5zqm6
12 Sep 17
Departure of Directors or Certain Officers
12:00am
8-K
7kl7byst00olb6j
9 Aug 17
VolitionRx Limited Announces Second Quarter 2017 Financial Results and Business Update
12:00am
8-K
cdz8 xf3to
19 Jul 17
Entry into a Material Definitive Agreement
12:00am
8-K
t9qr987
16 May 17
VolitionRx Limited Announces First Quarter 2017 Financial Results and Business Update
12:00am
8-K
xl0acsfsq6zmtwb4
12 Apr 17
VolitionRx Appoints David Vanston as Chief Financial Officer
12:00am
8-K
7wmlpnw gnkqryh
16 Mar 17
VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update
12:00am
424B3
eao6kf42x n2x
13 Dec 16
Prospectus supplement
12:00am
8-K
znpopc3b
6 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
yn7l7 wgd5
15 Nov 16
VolitionRx Limited Announces Third Quarter 2016 Financial Results and Business Update
12:00am